Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026

$3,995.00

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2021 to 2026

Publication date
March 2026
Number of pages
450+
Product type
Research report
Report edition
8
SKU
CP2053

Benchmark Manufacturing and Supply Partnerships Across the Global Biopharma Industry

Free report sample

The Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology report provides a comprehensive analysis of manufacturing and supply partnerships across the global life sciences industry. Designed for business development, licensing, and operations professionals, the report delivers detailed insight into how companies structure manufacturing agreements, negotiate financial terms, and establish supply relationships to support drug development and commercialization.

Fully revised and updated, the report provides a comprehensive listing of manufacturing and supply deals announced in recent years, drawn from the Current Agreements deals and alliances database. Each deal record includes financial information where available and links to detailed online deal records and contract documents filed with regulators when publicly disclosed.

By combining detailed deal data, financial benchmarking, and access to real contract documents, the report provides valuable intelligence for evaluating potential partners, structuring supply agreements, and negotiating more effective manufacturing partnerships.


Key Benefits

Save Significant Research Time
Access a consolidated database of manufacturing and supply agreements instead of searching multiple databases, press releases, and regulatory filings.

Benchmark Manufacturing and Supply Deal Structures
Understand how pharmaceutical and biotechnology companies structure manufacturing and supply partnerships, including responsibilities, operational roles, and long-term supply arrangements.

Analyze Financial Terms with Confidence
Review disclosed financial terms and transaction values to benchmark the commercial structure of comparable manufacturing agreements.

Access Real Contract Documents
Where available, explore SEC-filed manufacturing and supply agreements, providing deeper insight into the detailed contractual provisions behind real-world partnerships.

Identify Leading Manufacturing and Supply Dealmakers
Discover which companies are most active in manufacturing partnerships and analyze their outsourcing and supply chain strategies.

Track Industry Trends
Analyze manufacturing and supply dealmaking trends across companies, therapeutic areas, and technology types to understand how outsourcing and production strategies are evolving.


What’s Included in the Report

  • Analysis of manufacturing and supply dealmaking trends

  • Overview of manufacturing and supply agreement structures

  • Review of the leading manufacturing and supply deals by value

  • Profiles of the most active manufacturing and supply dealmakers

  • Detailed analysis of deals organized by company, therapeutic area, technology type, and industry sector

  • A comprehensive deal directory covering manufacturing and supply agreements recorded in the Current Agreements database

  • Links to online deal records and contract documents where available


Due Diligence Insights from Real Agreements

By reviewing actual manufacturing and supply contracts, the report enables users to evaluate key partnership provisions such as:

  • Manufacturing responsibilities and production commitments

  • Supply terms and commercial obligations

  • Financial payment structures and pricing mechanisms

  • Exclusivity provisions and territorial supply rights

  • Quality control and regulatory compliance responsibilities

  • Contract duration and termination provisions

Contract documents provide critical insight into the detailed terms negotiated between partners—information that is often not available in press releases or traditional deal databases.


Why This Report Matters

Manufacturing and supply partnerships are essential to the successful development and commercialization of pharmaceutical and biotechnology products. Companies increasingly rely on external partners to scale production, expand capacity, and access specialized manufacturing technologies.

By providing comprehensive deal data, financial benchmarking, and access to real contract documents, this report delivers the intelligence needed to structure stronger manufacturing partnerships, evaluate outsourcing strategies, and negotiate more effective supply agreements.

Key Benefits

Save Significant Research Time
Access a consolidated database of manufacturing and supply agreements instead of searching multiple databases, press releases, and regulatory filings.

Benchmark Manufacturing and Supply Deal Structures
Understand how pharmaceutical and biotechnology companies structure manufacturing and supply partnerships, including responsibilities, operational roles, and long-term supply arrangements.

Analyze Financial Terms with Confidence
Review disclosed financial terms and transaction values to benchmark the commercial structure of comparable manufacturing agreements.

Access Real Contract Documents
Where available, explore SEC-filed manufacturing and supply agreements, providing deeper insight into the detailed contractual provisions behind real-world partnerships.

Identify Leading Manufacturing and Supply Dealmakers
Discover which companies are most active in manufacturing partnerships and analyze their outsourcing and supply chain strategies.

Track Industry Trends
Analyze manufacturing and supply dealmaking trends across companies, therapeutic areas, and technology types to understand how outsourcing and production strategies are evolving.

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in manufacturing and supply dealmaking

2.1. Introduction

2.2. Definition of manufacturing and supply deal

2.3. Trends in manufacturing and supply deals since 2021

2.3.1. Manufacturing and supply dealmaking by year

2.3.2. manufacturing and supply dealmaking by phase of development

2.3.3. Manufacturing and supply dealmaking by industry sector

2.3.4. Manufacturing and supply dealmaking by therapy area

2.3.5. Manufacturing and supply dealmaking by technology type

2.3.6. Manufacturing and supply dealmaking by most active company

2.4. Reasons for entering into manufacturing and supply partnering deals

2.5. The future of manufacturing and supply deals

 

Chapter 3 – Overview of manufacturing and supply deal structure

3.1. Introduction

3.2. manufacturing and supply agreement structure

 

Chapter 4 – Leading manufacturing and supply deals

4.1. Introduction

4.2. Top manufacturing and supply deals by value

 

Chapter 5 – Top 25 most active manufacturing and supply dealmakers

5.1. Introduction

5.2. Top 25 most active manufacturing and supply dealmakers

 

Chapter 6 – manufacturing and supply deals including contracts directory

6.1. Introduction

6.2. manufacturing and supply deals with contracts

 

Deal directory

Deal directory – manufacturing and supply dealmaking by companies A-Z

Deal directory – manufacturing and supply dealmaking by therapy area

Deal directory – manufacturing and supply dealmaking by technology type

 

About Biopharma Research Ltd

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

TABLE OF FIGURES

Figure 1: Definition of manufacturing and supply

Figure 2: Trends in manufacturing and supply deal announcements

Figure 3: Manufacturing and supply deals signed at each phase of development

Figure 4: Manufacturing and supply deals by industry sector

Figure 5: Manufacturing and supply deals by therapy area

Figure 6: Manufacturing and supply deals by technology type

Figure 7: Top 25 most active manufacturing and supply dealmakers

Figure 8: Top manufacturing and supply deals by value

Figure 9: Most active manufacturing and supply dealmakers

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $7,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1ST Biotherapeutics, 4C Labs, 4D Pharma, 111, 180 Life Sciences, 908 Devices, AAVantgarde, AavantiBio, AAVnerGene, Abbvie, Abcam, Abera Bioscience, Ab Initio, Ablaze Pharmaceuticals, ABL Bio, Abogen Biosciences, AbTis, Abzena, Accelerated Biosciences, AcedrA BioPharmaceuticals, Ache, Achilles Therapeutics, Acino Pharma, Acorda Therapeutics, Actinium Pharmaceuticals, Actylis, Actym Therapeutics, AcuCort, Acuitas Therapeutics, Acumen Pharmaceuticals, Adagene, Adagio Therapeutics, Adaptimmune, Adhex Pharma, Adjupharm, Advancell, Advanz Pharma, Aegea Biotechnologies, Aeglea BioTherapeutics, Aerami Therapeutics, Aerogen, Affinia Therapeutics, AGC Biologics, Agenus Bio, Aggrega Pharma, Agno Pharma, AgraFlora Organics International, Ajinomoto Bio-Pharma Services, Akanda, Akari Therapeutics, Akoya Biosciences, Akron BioProducts, Akston Biosciences, Aktis Oncology, Alamar Biosciences, Albany Molecular Research, Alberta Cell Therapy Manufacturing, Alcami, Alcon Laboratories, Aldena Therapeutics, Aldevron, Aleafia Health, Aleph Farms, Algernon Pharmaceuticals, Alimera Sciences, ALK-Abello, Alkem Laboratories, Allarity Therapeutics, Allecra Therapeutics, Allergan Aesthetics, Allied Corp, AlloSource, Ally Biotech, Almelo, Alpha-9 Oncology, Alphamab Biopharmaceuticals, Alpha Teknova, Alphazyme, Alpine Immune Sciences, Altasciences, Altimmune, Alvotech, ALX Oncology, ALZpath, AM-Pharma, Amarin, Amasa Therapeutics, Amazon Web Services, Ambiopharm, American College of Lifestyle Medicine, Amgen, Amicrobe, Amneal Pharmaceuticals, Ampersand Capital Partners, AmplifyBio, Amyris, Analog Devices, Andelyn Biosciences, Angle, ANI Pharmaceuticals, Ankyra Therapeutics, Antengene, Anthony Nolan, Apipharm Veletrgovina, Apollon Formularies, Apotex, Applied Cells, Applied DNA Sciences, Applied Pharmaceutical Innovation, AptarGroup, Aquestive Therapeutics, Arabio, Aramis Biotechnologies, Arch Oncology, Arcturus Therapeutics, Ardena, Argonaut Manufacturing Services, Ariceum Therapeutics, Armas Pharmaceuticals, Armatus Bio, Arovella Therapeutics, ARS Pharmaceuticals, ARTBIO, Artes Biotechnology, Aruvant Sciences, ARWAN Pharmaceuticals, Asahi Kasei, Asahi Kasei Pharma America, Ascend Advanced Therapies, Ascend Therapeutics, Ascidian Therapeutics, Ascletis, ASC Therapeutics, Asher Bio, Asher Biotherapeutics, Asieris Pharmaceuticals, Asimov, Aslan Pharma, Aspargo Laboratories, Aspen Neuroscience, Assertio Therapeutics, Astellas Pharma, AstraZeneca, Atara Biotherapeutics, Atlas Antibodies, ATMA Journey Centers, AtomVie Global Radiopharma, Atsena Therapeutics, aTyr Pharma, AUM Biosciences, Aurigene Discovery Technologies, Australian Nuclear Science and Technology Organisation, Australian Research Council, Autolus Therapeutics, Avenzo Therapeutics, AVEO Oncology, Averix Bio, Avia Pharma, Avicanna, Avida Global, Avid Bioservices, Avini Health, Avita Medical MENA, Avita Therapeutics, Awakn Life Sciences, Axantia, Axolabs, Axovia Therapeutics, Aytu BioPharma, Azurity Pharmaceuticals, Azzur Group, Bausch Health Companies, Bavarian Nordic, Baxter International, Bayer, Beacon Therapeutics, Be Biopharma, BeiGene, BeOne Medicines, Berkeley Lights, Beroni Group, Bespoke Gene Therapy Consortium, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Better Therapeutics, BevCanna, BevNology, Bharat Biotech, Bial, Bio-Thera Solutions, BioCellgraft, BioCentriq, Biocept, BioCina, Biocon, BioConnection, BIOCORP, BioCorRx, Biodextris, BioElpida, BIOEMTECH, Biofabri, BioInvent, Biolexis, BioLife Solutions, BiolineRX, Biological E, Biomedical Advanced Research and Development Authority, Biomica, BioNano Genomics, Biond Biologics, BioNTech, Biopas Laboratories, Biophytis, BioRestorative Therapies, BioSenic, BioSpring, Biovac, BioVaxys, BioVectra, BioXpress, BiVictriX Therapeutics, Blood Centers of America, Bloomios, Bluebird Bio, BlueJay Therapeutics, BlueSphere Bio, BlueWhale Bio, Boehringer Ingelheim, Bone Biologics, BOOST Pharma, Bora Pharmaceuticals, Boston Scientific, Bota Bio, Botanical Solution, Boundless Bio, Bracco Imaging, Breckenbridge Pharmaceutical, Brenus Pharma, BriaCell Therapeutics, Brickell Biotech, BridgeBio Pharma, BrightPath Biotherapeutics, Bristol-Myers Squibb, BWXT Medical, Byondis, C4 Therapeutics, Cabaletta Bio, Caeregen Therapeutics, Calder Biosciences, California Institute for Regenerative Medicine, Calyxt, Cambrex, Canada House Wellness Group, Canadian Blood Services, CanaQuest Medical, Cannabics Pharmaceuticals, Cannabis House, Cannabotech, CannaCure, CannaHive, Cannamedical Pharma, Cannim Australia, Canonic, Canopy Growth, CanSinoBIO, Cantourage, Capsida Biotherapeutics, Carbogen Amcis, Cardinal Health, Caring Cross, Carisma Therapeutics, CaroGen, Carrick Therapeutics, Cartessa Aesthetics, Cassava Sciences, Cassiopea, Castle Biosciences, Catalent, Catalyst Pharmaceuticals, Catamaran Bio, CBD Supply MD, Cediprof, Celcuity, Cell-Easy, Cell and Gene Therapy Catapult, Cellares, Cell BioEngines, CellBion, Cellectar Biosciences, Cellectis, Cellevolve Bio, Cellipont Bioservices, Cellistic, CellPoint, CellProThera, Cell Therapy Manufacturing Center, Celltrion, Cellular Goods, Cellumed, Cellusion, CellVax Therapeutics, Cell X Technologies, Celonic, Celsion, Celularity, Cenexi, Center for Breakthrough Medicines, Centers for Disease Control and Prevention, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Probe Development and Commercialization, Cerus, Charles River Laboratories, Checkmate Pharmaceuticals, ChemGenes, Chemomab Therapeutics, Chime Biologics, Chimeric Therapeutics, Chimerix, Chimeron Bio, Chinagene Tech, China Grand Pharmaceutical, China Medical System, ChromaDex, Cingulate, Citius Oncology, Citrine Medicine, City of Hope, Civica Rx, CKD Bio, Clarity Pharmaceuticals, Clearmind Medicine, Clear Within, Clinigen, Clover Biopharmaceuticals, Clovis Oncology, CN Bio, Coalition for Epidemic Preparedness Innovations, Coave Therapeutics, Codex DNA, Codexis, Codiak BioSciences, Coherus Biosciences, Collaborative Drug Discovery, Comera Life Sciences, Compass Therapeutics, Context Therapeutics, CONTINUUS Pharmaceuticals, Convergent Therapeutics, Cook MyoSite, CORAT Therapeutics, CordenPharma, Corden Pharma, Core Biogenesis, Cosma Cannabis, Cosmo Pharmaceuticals, COVAX, CreaGen Biosciences, Cream of the Crop Therapeutics, Crescita Therapeutics, Cristalia, Croda, CROMA Pharma, Crossject, CSI Laboratories, CSL, CTMC, Curadh MTR, Cure Stat Rx, CureVac, Curia, Curie Therapeutics, Curium Pharma, Curocell, Curtana Pharmaceuticals, CyanVac, Cyclotek, Cynata Therapeutics, Cytiva, Cytovance Biologics, Cytovation, Cyxone, Daavlin, Daiichi Sankyo, Dalton Pharma Services, DaVita, Debiopharm, Decibel Cannabis Company, Decibel Therapeutics, Defense Threat Reduction Agency, Delta 9 Cannabis, Demetrix, Dendreon, Department of Defense, Department of Health and Human Services, Dermapharm, Dermata Therapeutics, Desert Medical Campus, Designs for Health, DIOSynVax, Dispatch Bio, DisperSol Technologies, Diverchim, DolCas Biotech, Dong-A Pharmaceutical, Dr. Reddy's Laboratories, Dryworld, DSM Nutritional Products, Dyadic International, DyDo Pharma, DynamiCure Biotechnology, Dynavax Technologies, Earendil Labs, Eckert & Ziegler, Eczacıbasi-Monrol, Edenbridge Pharmaceuticals, Eikonoklastes Therapeutics, Eirion Therapeutics, Eisai, Eko, Elanco, ElectroCore, ElevateBio, Elicio Therapeutics, Eli Lilly, Elite Pharmaceuticals, Elpida Therapeutics, Emercell, Emergent BioSolutions, Emergex Vaccines, Enable Injections, Endo International, Endo Ventures, Endpoint Health, EnGeneIC, Enlivex, Ensysce Biosciences, Enthusiasmus, Entos Pharmaceuticals, Entourage Health, Entourage Phytolab, Enveric Biosciences, Enzolytics, Enzychem Lifesciences, Er-Kim, Erasca, Ernexa Therapeutics, ESCO Aster, ESSA Pharma, Esteve, Ethris, Eton Pharmaceuticals, Etta Biotech, Eubiologics, Eucure Biopharma, Eureka Therapeutics, Eurofarma, Eurofins Scientific, European Commission, European Union, EVA Pharma, EV Biologics, Eve & Co, Everads Therapy, Evergreen Theragnostics, Evofem Biosciences, Evologic Technologies, Evolutionary Biologics, Evonetix, Evonik Industries, Evopoint Biosciences, Evotec, Exacis Biotherapeutics, Exactech, Exact Sciences, ExcellGene, Excellos, ExCellThera, Exela Pharma Sciences, Exelixis, ExeVir Bio, Exothera, Experion Biotechnologies, Eyedetec Medical, Farmalider, Feel Ventures, Fennec Pharmaceuticals, Ferring Pharmaceuticals, Fesarius Therapeutics, FibroBiologics, Filament Health, Fina Biosolutions, Flare Therapeutics, Flowserve, Fonterra, ForDoz Pharma, Forge Biologics, Formycon, French National Blood Service, Fresenius Kabi Pharmaceuticals, Fujifilm, Fujifilm Diosynth Biotechnologies, Fusion Pharmaceuticals, FutureChem, Future Pak, G42 Healthcare, Galapagos, Galecto, Gallery Brands, GAMA, Garuda Therapeutics, Gates Biomanufacturing Facility, Gates Medical Research Institute, GAVI Alliance, GBI BioManufacturing, GB Sciences, GC Biopharma, GC Cell, GE Healthcare, GeneCraft, GeneFab, Genentech, General Graphene, Genesis Pharma, Genetix Biotherapeutics, Genezen, GenFleet Therapeutics, Genmab, Genome and Company, GenomeFrontier Therapeutics, Genpharm, GenScript Biotech, GenScript ProBio, GentiBio, Geocann, George Medicines, German Government, Getinge, GI Innovation, Gilead Sciences, Ginkgo BioWorks, Givaudan, Glenmark Generics Inc USA, Glenmark Pharmaceuticals, Global Antibiotic Research and Development Partnership, Global Medical Solutions, Glycostem Therapeutics, Glytherix, go NXT LVL, Government of Argentina, Government of Australia, Government of Bahrain, Government of Canada, Government of Germany, Government of Israel, Government of Japan, Government of Singapore, Government of South Korea, Government of Switzerland, Government of The Philippines, Grace Fine Chemicals, Gracell Biotechnologies, Grand River Aseptic Manufacturing, Great Ormond Street Hospital (GOSH), Greenlight Biosciences, Green Stripe Naturals, Grey Wolf Therapeutics, Grifols, GSK, GT Biopharma, GT Medical Technologies, HaemaLogiX, Hainan Visum Pharmaceutical, Haisco Pharmaceutical, Halberd, Halix, Hamilton Company, HanchorBio, Hande Sciences, Handok Pharmaceuticals, Hangzhou Chance Pharmaceuticals, Hangzhou Diagens Biotechnology, Hanmi Pharmaceutical, Hansa Biopharma, Hanuman Pelican, Harm Reduction Therapeutics, Harpoon Therapeutics, Harvest One, Havn Life Sciences, Healis Therapeutics, Health and Happiness Group, HealthTech Connex, Helsinn Healthcare, Hememics Biotechnologies, Hemogenyx, Hempacco, Hempsana, Henlius Biotech, Heritage Cannabis, Hexo, HiFiBio, Hoffmann La Roche, Hollister Biosciences, Hope Medicine, Horizon Europe, Hoth Therapeutics, Hovione, HSS, HTL Biotechnology, Hualan Biological Bacterin, Hubble Therapeutics, Humanigen, Hummingbird Bioscience, Hygio, I-mab, Iambic Therapeutics, IBA, IDEAYA Biosciences, IDT Biologika, iECURE, IlmixGroup, Imagene Labs, ImaginAb, Imagine Pharmaceuticals, Immedica, Immix Biopharma, Immune-Onc Therapeutics, Immuneel Therapeutics, Immuneering, ImmunityBio, ImmunoAdoptive Cell Therapy, Immunocore, Immunome, ImmunoPrecise Antibodies, Immunovia, Immutep, Immuthera, IMP Clinical Supply Services, Imperial College London, Implant Therapeutics, Imugene, IN8bio, Incyclix Bio, Incyte, Indaptus Therapeutics, InfectoPharm, Infex Therapeutics, Infinimmune, InflaRx, Ingredion, INmune Bio, Innovent Biologics, Institute of Molecular Biology of Paraná (IBMP), Intas Pharmaceuticals, IntelGenx, InterCure, Interius BioTherapeutics, International Agencies (Bangladesh), Intravacc, inviCRO, InvivoGen, Ionetix, Ionis Pharmaceuticals, Irwin Naturals, Isotopia Molecular Imaging, Istari Oncology, ITM Isotopen Technologien, iTolerance, Ixaka, J-STAR Research, Jacobio Pharmaceuticals, Jaeb Center for Health Research Foundation, Jaguar Health, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Government, Jazz Pharmaceuticals, jCyte, Jiangsu Aosaikang Pharmaceutical, Johns Hopkins University, Johnson & Johnson, JS Biosciences, Jubilant Hollisterstier, Jumpcan Pharmaceutical, Juniper Biologics, Junshi Biosciences, Justera Health, KAHR Medical, Kaken Pharmaceutical, KaliVir Immunotherapeutics, Kamada, Kanabo Research, Karyopharm Therapeutics, Kashiv BioSciences, Kate Therapeutics, KBI BioPharma, Kedrion Biopharma, Kemwell BioPharma, Kidswell Bio, Kincell Bio, Kindeva Drug Delivery, Kinectrics, Kineta, Kintor, KiOmed Pharma, Kissei Pharmaceutical, Kite Pharma, Klotho Neurosciences, Kolon Life Science, Kowa Pharmaceuticals America, Kriya Therapeutics, KromaTiD, KSQ Therapeutics, Kura Oncology, Kurma Life Sciences Partners, Kuva Labs, KVK-Tech, Kwangdong Pharmaceutical, KYE Pharmaceuticals, Kyowa Hakko Kirin Pharmaceuticals, Kytopen, Kyverna Therapeutics, Laboratory Corporation of America, LakePharma, Landmark Bio, Lannett, Lava Therapeutics, LegoChem Biosciences, Leibniz-Institut fur Molekulare Pharmakologie, Lentigen, Lepu Biopharma, Leucid Bio, Lexaria Bioscience, LEXEO Therapeutics, LFB Group, LianBio, Life Biosciences, Lifecore Biomedical, LifeMD, Life Molecular Imaging, Lifenet, Lifera, LifeSouth Community Blood Centers, LIfT BioSciences, Lindy Biosciences, Lineage Cell Therapeutics, Lipella Pharmaceuticals, Lipocine, Lipomedix Pharmaceuticals, Lisata Therapeutics, Lonza, LOTTE Biologics, Lumicks, Lune Rise Farms, Lupagen, Lupin, Lupin Limited, Luxna Biotech, Lyndra Therapeutics, M8 Pharmaceuticals, MaaT Pharma, Macrocyclics, Made Scientific, Madrigal Pharmaceuticals, MagnaPharm Group, MAIA Biotechnology, Mannin Research, Maple Leaf Green World, Maplex Naturals, Marengo Therapeutics, Marinus Pharmaceuticals, Marker Therapeutics, Maruho, Matai Medical Research Institute, Maxcyte, MaxiVAX, Mayo Clinic, Maypro, MD Anderson Cancer Center, Medac, Medexus Pharmaceuticals, Medicenna Therapeutics, Medichem International, MediLink Therapeutics, MediPharm Labs, Medisca, Medivir, Medline Industries, Medomie Pharma, MedPacto, Medsenic, Meilleur Technologies, Meitheal Pharmaceuticals, Menarini, Mendus, Merck and Co, Merck KGaA, Meridian Medical Technologies, MetasTx, Metsera, Miltenyi Biotec, MiMedx, Minapharm, Minaris Regenerative Medicine, Mindset Pharma, MinervaX, Mirati Therapeutics, Miravo Healthcare, miRecule, Mirror Biologics, Mithra Pharmaceuticals, Mitsubishi Chemical, Mitsubishi Tanabe Pharma, Moderna, Modus Therapeutics, Molecular Targeting Technologies, MolMed, Monash University, Mongoose Bio, Montreal Cannabis Medical, MoonLake Immunotherapeutics, Moonlight Bio, Morocco Ministry of Health, MPB Group, MSD, MSD Wellcome Trust Hilleman Laboratories, MS Pharma, MTF Biologics, Multiply Labs, Mycotopia Therapies, Mydecine Group, Myrtelle, Mytos, n-Lorem Foundation, Nabriva Therapeutics, Nalu Bio, Nanjing King-friend Biochemical Pharmaceutical, Nanjing Leads Biolabs, Nanoform, Nanoscope Therapeutics, National Center for Advancing Translational Sciences (NCATS), National Health Service, National Institute of Diabetes and Digestive and Kidney Diseases, National Resilience, Nautilus Biotech, Navamedic, Navega Therapeutics, NEC Bio Therapeutics, Nektar Therapeutics, Nemysis, Neoletix Biotechnology, Neoleukin Therapeutics, NeoPharm, Nephron Pharmaceuticals, Nestle Health Science, NeuExcell, Neurizon Therapeutics, NewBridge Pharmaceuticals, New Hope Research Foundation, Newly Institute, Nexcella, Next Generation Manufacturing Canada, Nextleaf Solutions, NextPharma, NFL Biosciences, NGM Biopharmaceuticals, NiKang Therapeutics, Niowave, Nirvana Life Sciences, Nivagen Pharmaceuticals, Nkarta Therapeutics, Noble Growth, Noble Life Sciences, Norgine, Northern RNA, North Star Holdings, NorthStar Medical Radioisotopes, Northway Biotechpharma, NorthX Biologics, Nouscom, NovalGen, Novartis, Novasep, Novavax, Novelty Nobility, Novocol Pharma, NRG Oncology, NRx Pharmaceuticals, Nuance Pharma, Nucleus Biologics, Nucleus RadioPharma, Nuclidium, Nusano, Nutra Pharma, Nutriband, Nuvisan Pharma Services, NX Development, Nxera Pharma, Nykode Therapeutics, Oakland Health, Obio, Ocugen, Oculogenex, Odimma Therapeutics, OG Laboratories, Olema Oncology, Olon, OmniaBio, Onco-Innovations, OncoC4, OncoNano Medicine, OncoOne, OncoSec Medical, Oncternal Therapeutics, On Demand Pharmaceuticals, ONK Therapeutics, ONL Therapeutics, Open Orphan, Opentrons Labworks, Opiostop, Opticann, Optieum Biotechnologies, Optimi Health, Optimvia, Opus Genetics, Oravax Medical, Orchard Therapeutics, Organigram, Ori Biotech, ORIC Pharmaceuticals, Orient EuroPharma, Orion, Orpharm, ORPHELIA Pharma, Ortho Regenerative Technologies, Oryx Isotopes, Otsuka, Ottawa Hospital Research Institute, Ovation Science, Oxford BioMedica, Pacira Biosciences, Padagis, Paladin Labs, Pall Corporation, panCELLa, Panolos Bioscience, PanOptica, Pantera, Paratek Pharmaceuticals, Parse Biosciences, Parthenon Therapeutics, Parvus Therapeutics, Pasithea Therapeutics, Pathway Health, PCI Pharma Services, PENAO, PeptiSystems, Persist AI, Perspective Therapeutics, Petros Pharmaceuticals, Pfizer, Phanes Therapeutics, PharmaJet, PharmAla Biotech, Pharmalink, PharmaLogic, Pharmanovia, Pharmapark, Pharmaron, PharmaTher, PhaseBio Pharmaceuticals, Phathom Pharmaceuticals, Phebra, Philochem, Philogen, Phlow, Phokam Pharmaceutical, Pierre Fabre, Pioneer Knop Laboratorios, Piramal, Plantations Ceres, Pluristem Therapeutics, Pluristyx, Plus Therapeutics, PlusVitech, PMV Pharma, POINT Biopharma, Polifarma, Polpharma, PolyPeptide Group, Polypeptide Therapeutic Solutions, Poly Pharmaceuticals, Portage Biotech, Prasco Laboratories, Precirix, Precision Molecular, Precision NanoSystems, Prelude Therapeutics, Premier Inc, Pressure BioSciences, Prestige BioPharma, Primrose Bio, ProBioGen, Promises Innovative Recovery Center, ProteoMediX, Provectus Biopharmaceuticals, ProvideGx, Providence Therapeutics, Prozomix, PsiVac, Psyence Biomedical, Psygen Labs, Public Health Agency of Canada, PurCann Pharmaceuticals, Pure Extracts Technologies, PureForm Global, Pure Origin, Purespring Therapeutics, PureTech Health, Purisys, Q-Gen Cell Therapeutics, Q BioMed, Qilu Pharmaceutical, Qkine, QSAM Biosciences, Qualigen, Quality Chemical Laboratories, Quallent Pharmaceuticals, Quantoom Biosciences, QuantumDx, Queensland Institute of Medical Research (QIMR), Quell Therapeutics, Quoin Pharmaceuticals, Race Oncology, Radiomedix, Radiopharm Theranostics, Radius Health, Rain Oncology, Rakuten Medical, Rani Therapeutics, Rapid Dose Therapeutics, Rapid Novor, Ratio Therapeutics, Ray Therapeutics, RC2, Recipharm, Recordati, Recro Pharma, RedHill Biopharma, Regeneron Pharmaceuticals, Regenity Biosciences, Regenxbio, RemeGen, Rentschler Biotechnologie, Repair Biotechnologies, Replay, Replimune, Resilience, Res Nova Bio, Respira Technologies, RespireRx Pharmaceuticals, Retro Biosciences, Revance Therapeutics, Revive Therapeutics, Revolo Biotherapeutics, RevOpsis Therapeutics, Richter-Helm BioLogics, Ridgeback Biotherapeutics, Rigel Pharmaceuticals, Rivaara Immune, RK Pharma, RLS, Roche, Rocket Pharmaceuticals, Rockwell Medical, Ro Invest, RoslinCT, Russian Direct Investment Fund, Ryvu Therapeutics, Rznomics, S.Biomedics, SAB Biotherapeutics, Safer Medical of Montana, Samsung Biologics, Sandoz, Sanofi, SaNOtize Research and Development, Sansure Biotech, Santhera Pharmaceuticals, SaponiQx, Sapphiros, Sarepta Therapeutics, Scancell, SCK CEN, Scorpius BioManufacturing, Scottish Enterprise, Searchlight Pharma, Seattle Genetics, Secretome Therapeutics, Seelos Therapeutics, Seibersdorf Laboratories, Selexis, Sen-Jam Pharmaceutical, Senhwa Biosciences, Sensei Biotherapeutics, Senti Biosciences, Seppic, Seqens, Seqirus, SERB Pharmaceuticals, Serum Institute of India, Sesen Bio, Shanghai ChemPartner, Shanghai Lishan Biopharmaceuticals, Sharps Technology, Shilpa Biologicals, Shine Medical Technologies, SHINE Technologies, Shionogi, Shonan-Kamakura General Hospital, Shoreline Biosciences, Showa Denko, ShroomBloom, Shuttle Pharmaceuticals, Sichuan Deebio Pharmaceutical, SIGA Technologies, Silexion Therapeutics, SiliCycle, Silverback Therapeutics, Simcere Pharmaceuticals, Sinclair Pharmaceuticals, Sino Biological, Sinopharm Group Beijing HuaHong, Sinorda Biomedicine, Sinovac Biotech, Siren Biotechnology, Sirona Biochem, Siva Therapeutics, SK Bioscience, SK Chemicals, SK Pharmteco, Skye Bioscience, Slingshot Biosciences, Smart Automated Retail Network, SmartCella, Societal CDMO, Solid Biosciences, Soligenix, Solumedics, SOMAI Pharmaceuticals, Somite Therapeutics, Sona Nanotech, Sonnet BioTherapeutics, SonoThera, SPC Korea, Specialised Therapeutics, SpectronRx, Spectrum Pharmaceuticals, SpectrumX, SpringWorks Therapeutics, Sproutly, SPT Labtech, St. Peter’s Drinks, STADA Arzneimittel, Stanford University, Starget Pharma, State B Cannabis Beverages, Stedical Scientific, SteinCares, Stelis Biopharma, StemCyte, Steriscience, Storm Therapeutics, Strides Pharma Science, Suanfarma, Summit Biosciences, Sunovion Pharmaceuticals, Sun Pharmaceutical, SunRock Biopharma, Supriya Lifescience, Suzhou Porton Advanced Solutions, Suzhou Ribo Life Science, Syena, Symbiosis, Symeres, Syna Therapeutics, Synimmune, Synthekine, Synthon, Syros Pharmaceuticals, T-Cure Bioscience, Tabuk Pharmaceuticals, Taiho, TaiMed, Taiwan Ministry of Economic Affairs, Takeda Pharmaceutical, Takeda Pharmaceuticals U.S.A, Tallac Therapeutics, Tanner Pharma, Tanner Pharmaceuticals, Tanvex Biologics, Targovax, TargTex, TC BioPharm, TCG GreenChem, Teijin, Tela Bio, Telix Pharmaceuticals, Tempest Therapeutics, Tenacia Biotechnology, TerraPower, TerThera, Tetra Bio-Pharma, Tetris Pharma, Teva Pharmaceutical Industries, Teva Pharmaceuticals USA, Tevogen Bio, TheracosBio, Theragent, Theratechnologies, Thermo Fisher Scientific, Thor Medical, Tianjin CanSino Biotechnology, Tikun Olam, Tikun Olam-Cannbit, TILT Biotherapeutics, Tivic Health Systems, TLC BioSciences, Tnuva Group, Todos Medical, Together Pharma, Touchlight, TRACON Pharmaceuticals, Transgene, Trevena, TriLink BioTechnologies, TriSalus Life Sciences, TRIUMF, Triumvira Immunologics, Turn Therapeutics, Twist Bioscience, UK Government, Undisclosed Company, Uniphar, UniQure, United Nations Children Fund, United States Pharmacopeia, Universal Ibogaine, University College London, University of Alabama at Birmingham, University of California, University of Louisville, University of Miami, University of Pennsylvania, UroGen Pharma, UroGPO, US Government, Valens Company, ValenzaBio, Valeo Pharma, Valneva, Valo Therapeutics, Vaxcyte, Vaxine, Vector BioMed, VenatoRx, Verismo Therapeutics, Vertex Pharmaceuticals, Veru, Veterans For Healing, Vetter, VHA, Vianex, Viewpoint Molecular Targeting, Viking Therapeutics, Vinbiocare Biotechnology, Vineti, Viralgen, Vir Biotechnology, Virchow Biotech, Virica Biotech, Virion Therapeutics, ViroCell Biologics, Virpax Pharmaceuticals, Visgenx, Vizient, Vor Biopharma, Wacker Biotech, Waisman Biomanufacturing, Watchmaker Genomics, Welding, WellDoc, Wellmarker Bio, West Pharmaceutical Services, Willow Biosciences, Wilson Wolf, Windtree Therapeutics, W L Gore, WUGEN, WuXi Advanced Therapies, WuXi Biologics, Wuxi STA, WuXi XDC, X4 Pharmaceuticals, XBiotech, Xcellbio, Xenetic Biosciences, XERIS Pharmaceuticals, Xi'an Beilin Pharmaceutical, XPhyto Therapeutics, Xuanzhu Biopharma, XyloCor Therapeutics, YASKAWA Electric, Yield10 Bioscience, Ypsomed, Yuhan Corporation, Yunnan Walvax Biotech, Zag Bio, ZandCell, Zentalis Pharmaceuticals, Zentiva, Zhaoke (Hong Kong) Ophthalmology Pharmaceutical, Zhejiang Ausun Pharmaceutical, Zhejiang Yonghe Pharmaceutical Technology, Ziphius Vaccines, Zydus Cadila, Zydus Lifesciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.